The role of S-nitrosoglutathione reductase (GSNOR) in human disease and therapy.
The role of S-nitrosoglutathione reductase (GSNOR) in human disease and therapy.
复制标题
DOI:
10.1080/10409238.2017.1304353
复制
发表时间:
2017-06
影响因子:
6.5
通讯作者:
Buxton ILO
中科院分区:
文献类型:
--
作者:
Barnett SD;Buxton ILO
S-nitrosoglutathione reductase (GSNOR), or ADH5, is an enzyme in the alcohol dehydrogenase (ADH) family. It is unique when compared to other ADH enzymes in that primary short-chain alcohols are not its principle substrate. GSNOR metabolizes S-nitrosoglutathione (GSNO), S-hydroxymethylglutathione (the spontaneous adduct of formaldehyde and glutathione), and some alcohols. GSNOR modulates reactive nitric oxide (•NO) availability in the cell by catalyzing the breakdown of GSNO, and indirectly regulates S-nitrosothiols (RSNOs) through GSNO-mediated protein S-nitrosation. The dysregulation of GSNOR can significantly alter cellular homeostasis, leading to disease. GSNOR plays an important regulatory role in smooth muscle relaxation, immune function, inflammation, neuronal development, and cancer progression, among many other processes. In recent years, the therapeutic inhibition of GSNOR has been investigated to treat asthma, cystic fibrosis and interstitial lung disease (ILD). The direct action of •NO on cellular pathways, as well as the important regulatory role of protein S-nitrosation, are closely tied to GSNOR regulation and define this enzyme as an important therapeutic target.
登录
查看更多内容
影响因子:
7.7
作者:
Carvalho, MA;Ueno, M;Saad, MJA
通讯作者:
Saad, MJA
DOI:
10.1073/pnas.1113319109
发表时间:
2012-03-13
影响因子:
11.1
作者:
Beigi, Farideh;Gonzalez, Daniel R.;Hare, Joshua M.
通讯作者:
Hare, Joshua M.
DOI:
10.1073/pnas.82.24.8369
发表时间:
1985-12-01
影响因子:
11.1
作者:
BEISSWENGER, TB;HOLMQUIST, B;VALLEE, BL
通讯作者:
VALLEE, BL
影响因子:
3.8
作者:
Bonaventura, C;Godette, G;Henkens, R
通讯作者:
Henkens, R
DOI:
10.1124/jpet.110.171934
发表时间:
2010-10-10
影响因子:
3.5
作者:
Buxton, Iain L. O.;Milton, Deanna;Tichenor, Stephen D.
通讯作者:
Tichenor, Stephen D.